Legal Representation
Attorney
Patrick J. Concannon
USPTO Deadlines
Next Deadline
1246 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-12-25)
Due Date
December 25, 2028
Grace Period Ends
June 25, 2029
Application History
45 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 11, 2025 | C8.. | O | CANCELLED SEC. 8 (6-YR) | Loading... |
Dec 25, 2023 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
Jun 14, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Dec 25, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Nov 17, 2018 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
Nov 16, 2018 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
Oct 30, 2018 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Oct 29, 2018 | IUAF | S | USE AMENDMENT FILED | Loading... |
Oct 29, 2018 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Apr 28, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 27, 2018 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Apr 25, 2018 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Apr 25, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 26, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 24, 2017 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Oct 24, 2017 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Oct 24, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 27, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 25, 2017 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Apr 25, 2017 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Apr 25, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Nov 15, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Nov 12, 2016 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Nov 10, 2016 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Oct 25, 2016 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Oct 25, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 25, 2016 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Apr 28, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 26, 2016 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Apr 26, 2016 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Apr 26, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 26, 2016 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Oct 27, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Sep 1, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Sep 1, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Aug 12, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Aug 12, 2015 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jul 24, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Jul 22, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jul 22, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 7, 2015 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
May 4, 2015 | ALIE | A | ASSIGNED TO LIE | Loading... |
Apr 30, 2015 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
Apr 21, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Apr 17, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Additional Information
Design Mark
The mark consists of the word "CONCERT" with the "O" in lower case form and the "N" larger than the other upper case characters with the words "PHARMACEUTICALS INC." appearing in title case below "CONCERT".
Color Claim
Color is not claimed as a feature of the mark.
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS INC."